Overview
Dr. Jenkins obtained his Bachelor's degree in biology at the University of Virginia in 2002 and his MD/PhD at the Medical University of South Carolina in 2012. He completed his internship and residency in Internal Medicine at Massachusetts General Hospital in 2014 and his clinical oncology training in the Dana-Farber/Harvard Cancer Center in 2017. He conducted his post-doctoral research in Dr. David Barbie's lab at the Dana-Farber Cancer Institute where he developed a novel platform to study ex vivo response to PD1- blockade using organotypic tumor spheroids. In 2018, he joined the faculty at the MGH Cancer Center in the Center for Melanoma and Center for Cancer Research and was an Associate Member of the Cancer Program at the Broad Institute of MIT and Harvard. Dr. Jenkins was the inaugural Termeer Early Career Investigator in Systems Pharmacology, and member of the Laboratory for Systems Pharmacology at Harvard Medical School. Dr. Jenkins returned to MUSC in 2025 as the Cecilia and Vincent Peng Endowed Chair in Melanoma and Cutaneous Oncology with appointments in the Department of Medicine, Division of Hematology-Oncology, Department of Dermatology and Dermatologic Surgery, and Department of Pharmacology \& Immunology. The Jenkins laboratory studies mechanisms of response and resistance to immune checkpoint blockade and adoptive cellular therapy with a focus on developing rational combination therapies to overcome resistance to cancer immunotherapy.
Dr. Jenkins is highly rated in 1 condition, according to our data. His clinical expertise encompasses Melanoma, Niemann-Pick Disease, Non-Langerhans-Cell Histiocytosis, and Melanoma of the Eye.
He is actively involved in clinical research, co-authoring 66 peer reviewed articles. Dr. Jenkins is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
86 Jonathan Lucas St, 86 Jonathan Lucas St, Charleston, SC 29425
Additional Areas of Focus
Dr. Jenkins has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MUSC University Hospital
Robert Stuart is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Stuart is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.
MUSC Health Hematology Oncology At Hollings Cancer Center
Dr. Thai Ho has been caring for patients affected by genitourinary cancers for over 10 years. His area of expertise and the focus of his research is in treating kidney and bladder cancers. He also sees patients with kidney, bladder, upper tract urothelial, and prostate cancers, as well as patients affected by hereditary cancer syndromes. Dr. Ho completed the Baylor College of Medicine Physician Scientist Program in 2006, internal medicine residency at Washington University in St. Louis in 2009, and Medical Oncology Fellowship at MD Anderson Cancer Center in 2012.Dr. Ho's research is funded by the National Institutes of Health and Department of Defense to better match cancer patients with targeted therapies by using precision medicine approaches to identify a cancer's unique vulnerabilities. At MUSC Hollings Cancer Center, Dr. Ho is the Director of Precision Medicine and an Associate Professor in the Division of Hematology \& Oncology. Prior to joining MUSC, Dr. Ho was an Associate Professor faculty the Mayo Clinic where he was a member of the Center for Individualized Medicine Epigenomics Group, Genomic Tumor Board, and von Hippel-Lindau Clinic. Dr. Ho is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Nephrectomy, and Orchiectomy. Dr. Ho is currently accepting new patients.
Bon Secours St Francis Xavier Hospital Inc.
Gene Saylors is a Hematologist and an Oncologist practicing medicine in North Charleston, South Carolina. Dr. Saylors is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Colorectal Cancer, Pleuropulmonary Blastoma, Bone Marrow Aspiration, and Pancreatectomy. Dr. Saylors is currently accepting new patients.
Frequently Asked Questions about Dr. Russell W. Jenkins
How do I make an appointment with Dr. Russell W. Jenkins?
You can book an appointment with Dr. Russell W. Jenkins by calling their office at 843-792-9300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Russell W. Jenkins a top-rated expert for Melanoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Russell W. Jenkins is classified as an Distinguished expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Russell W. Jenkins specialize in?
While Dr. Russell W. Jenkins is a Hematology Oncology, they have specific expertise in Melanoma, Niemann-Pick Disease, and Non-Langerhans-Cell Histiocytosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Russell W. Jenkins participate in research or clinical trials?
Yes. Dr. Russell W. Jenkins has published 66 articles and abstracts on conditions like Melanoma. You can view a list of Dr. Russell W. Jenkins's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Russell W. Jenkins accept my insurance?
Dr. Russell W. Jenkins accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 843-792-9300 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MelanomaDr. Jenkins isDistinguished. Learn about Melanoma.
- Experienced
- HistiocytosisDr. Jenkins isExperienced. Learn about Histiocytosis.
- Melanoma of the EyeDr. Jenkins isExperienced. Learn about Melanoma of the Eye.
- Metastatic Uveal MelanomaDr. Jenkins isExperienced. Learn about Metastatic Uveal Melanoma.
- Niemann-Pick DiseaseDr. Jenkins isExperienced. Learn about Niemann-Pick Disease.
- Non-Langerhans-Cell HistiocytosisDr. Jenkins isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- Olfactory NeuroblastomaDr. Jenkins isExperienced. Learn about Olfactory Neuroblastoma.
- ReticulohistiocytomaDr. Jenkins isExperienced. Learn about Reticulohistiocytoma.
- Sinus CancerDr. Jenkins isExperienced. Learn about Sinus Cancer.
- TeratocarcinosarcomaDr. Jenkins isExperienced. Learn about Teratocarcinosarcoma.